Miller, R E
Sweeney, C J
Article History
Received: 18 October 2015
Revised: 29 November 2015
Accepted: 27 December 2015
First Online: 15 March 2016
Competing interests
: CJS has consultancy with honoraria for Astellas, BIND therapeutics, Sanofi, Janssen, Genentech and Bayer. The remaining author declares no conflict of interest.